Mizuho Asset Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$662K Sell
2,116
-870
-29% -$258K 0.14% 140
2016
Q2
$722K Buy
2,986
+1,468
+97% +$387K 0.13% 156
2016
Q1
$641K Sell
1,518
-1,392
-48% -$368K 0.17% 149
2015
Q4
$891K Buy
2,910
+326
+13% +$93.7K 0.18% 142
2015
Q3
$754K Buy
2,584
+435
+20% +$144K 0.17% 151
2015
Q2
$868K Buy
2,149
+631
+42% +$253K 0.2% 136
2015
Q1
$641K Buy
1,518
+425
+39% +$168K 0.17% 149
2014
Q4
$371K Buy
1,093
+322
+42% +$104K 0.11% 155
2014
Q3
$255K Buy
771
+170
+28% +$56.1K 0.05% 171
2014
Q2
$190K Buy
601
+162
+37% +$48.8K 0.04% 190
2014
Q1
$134K Hold
439
0.03% 199
2013
Q4
$123K Sell
439
-83
-16% -$21.5K 0.02% 199
2013
Q3
$126K Hold
522
0.02% 207
2013
Q2
$112K Buy
+522
New +$112K 0.02% 214

Other funds holding BIIB

Mizuho Asset Management's BIIB Position: Q3 2016 in Review

Mizuho Asset Management reduced its Biogen (BIIB) stake by 29% in Q3 2016, selling an estimated $258K and leaving 2,116 shares worth $662K. The position accounts for 0.14% of the portfolio, ranked #140.

Mizuho Asset Management first reported a position in BIIB in Q2 2013 and has held it in 14 quarters since. The position peaked at $891K in Q4 2015. 1,012 funds tracked by Wall St. Rank hold BIIB as of Q3 2016.

  • Mizuho Asset Management held 2,116 shares of Biogen worth $662K as of Q3 2016.
  • Mizuho Asset Management sold 870 Biogen shares in Q3 2016, an estimated $258K.
  • Biogen made up 0.14% of Mizuho Asset Management's portfolio in Q3 2016, its #140 holding.
  • Mizuho Asset Management first reported a position in Biogen in Q2 2013 and has held it in 14 quarters since.
  • Mizuho Asset Management's Biogen position peaked at $891K in Q4 2015.
  • 1,012 funds tracked by Wall St. Rank held Biogen as of Q3 2016.

Based on Mizuho Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.